There were no serious adverse events related to competition in a study of 129 young athletes with implantable cardioverter defibrillators (ICDs), providing reassurance that moderate-to-intense physical activity in this population may be safer than previously thought.

Individuals with clinical depression could face a more than seven-fold increased risk of atrial fibrillation (AF), especially in the earliest stages of their diagnosis, a population study out of Denmark suggests.

A decades-long study of patients who have migraines with visual aura has linked the painful headaches to an increased risk of experiencing atrial fibrillation and, to a lesser degree, stroke, researchers report in the online edition of Neurology.

When approached again, about a quarter of patients with atrial fibrillation (AFib) not taking anticoagulants due to physician-cited “patient refusal” said they would consider taking the drugs, according to preliminary research presented at the American Heart Association’s Scientific Sessions in Chicago.

For patients with nonvalvular atrial fibrillation (AFib), taking a direct oral anticoagulant (DOAC) instead of warfarin may cut the risk of dementia by 15 to 20 percent, according to a large database study published Nov. 2 in the Journal of the American Heart Association.

The American College of Cardiology, American Heart Association and Heart Rhythm Society on Nov. 6 released a new guideline for the evaluation and treatment of patients with bradycardia and cardiac conduction disorders.

A Stanford- and Apple-led atrial fibrillation study of more than 400,000 U.S. residents—the largest AFib screening effort to date—has entered its final phase of data collection, the company announced Nov. 1. The trial is expected to wrap up early next year.

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.